Want to join the conversation?
Wolfe Research analyst Scott Mushkin questions $UNFI on the revenue guidance, where taking out $160MM, is the core guided into the lower end of previous guidance. CFO Michael Zechmeister says that the top end annual guidance of $3.4-3.8MM is increased driven by the acquisitions.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?